2. 设定相关信息 # 获取的股票列表ticker_list=['600000.SH','600009.SH','600016.SH','600028.SH','600030.SH']# 需要添加的因子,当前支持两种因子库 stockstats 和 talib,默认使用 stockstatsTECHNICAL_INDICATORS_LIST=['macd','boll_ub','boll_lb','rsi_30','dx_30','close_30_sma','close_60...
AKHI | Complete Al Khaleej Takaful Group stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
精密基因医学公司Akouos(AKUS)涨87%,报13.09美元。 礼来(LLY)和Akouos宣布达成最终协议,由礼来收购Akouos。Akouos是一家精密基因医学公司,正在开发一系列腺相关病毒基因疗法,用于治疗包括感音神经性听力损失在内的内耳疾病。根据交易条款,礼来将以每股12.50美元的现金收购Akouos的所有流通股,外加一项不超过每股3美元的或...
006840 | Complete AK Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
orward Is Blue-Chip Szczerbiak Stock Soars; Forward Is Blue-ChipSzczerbiak Stock Soars; Forward Is Blue-ChipSteve Wyche
Stock Price Prediction If tomorrow:Open lowerOpen higher High:13.32 - 13.3913.39 - 13.44 Low:13.1 - 13.213.2 - 13.27 Close:13.16 - 13.313.3 - 13.41 Company Description Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic he...
William Blair分析师Sami Corwin予Akouos(AKUS)增持评级,目标价12美元。 Corwin在一份研究报告中告诉投资者,该公司正在开发一种直接进入内耳的基因疗法管道,以恢复和保存听力。这位分析师认为,对感音神经性听力损失的基因疗法“代表了腺相关病毒景观进化的下一个逻辑迭代”,因为内耳的解剖学和生物学具有与眼睛相似的优势...
Stock Split History 26 followers $72.880.1 (+0.14%)02/06/25 Mutual Fund |$USD |NAV SummaryHoldingsRatingsMomentumDividendsPeersCharting ChartingCharting Historical PricesHistorical Prices SplitsSplits We currently have no AKRSX Stock Split History on this stock. ...
stock exchanges. Investments consist primarily of common stocks of companies of any size market capitalization. It may also invest in preferred stocks, warrants, options, and other equity-like instruments, such as partnership interests, limited liability company interests, business trust shares and ...
A high-level overview of Akre Focus Fund Inst (AKRSX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.